Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Apr;43(4):532–536. doi: 10.1038/bjc.1981.76

Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.

Y D Shi, Z S Tang, Z J Lian, C Z Lu, B G Xiao
PMCID: PMC2010638  PMID: 6165370

Full text

PDF
532

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvilommi H., Dale M. M., Desai H. N., Mongar J. L., Richardson M. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer. Br J Cancer. 1977 Nov;36(5):545–549. doi: 10.1038/bjc.1977.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cercek L., Cercek B. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review. Eur J Cancer. 1977 Sep;13(9):903–915. doi: 10.1016/0014-2964(77)90166-9. [DOI] [PubMed] [Google Scholar]
  3. Dickinson J. P., Caspary E. A. The chemical nature of cancer basic protein. Br J Cancer Suppl. 1973 Aug;1:224–228. [PMC free article] [PubMed] [Google Scholar]
  4. Field E. J., Caspary E. A., Smith K. S. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation. Br J Cancer Suppl. 1973 Aug;1:208–214. [PMC free article] [PubMed] [Google Scholar]
  5. Goldstone A. H., Kerr L., Irvine W. J. The macrophage electrophoretic migration test in cancer. Clin Exp Immunol. 1973 Jul;14(3):469–472. [PMC free article] [PubMed] [Google Scholar]
  6. Hashimoto Y., Takaku F., Yamanaka T. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases. Br J Cancer. 1979 Jul;40(1):156–160. doi: 10.1038/bjc.1979.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lewkonia R. M., Kerr E. J., Irvine W. J. Clinical evaluation of the macrophage electrophoretic mobility test for cancer. Br J Cancer. 1974 Dec;30(6):532–537. doi: 10.1038/bjc.1974.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Light P. A., Preece A. W., Waldron H. A. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease. Clin Exp Immunol. 1975 Nov;22(2):279–284. [PMC free article] [PubMed] [Google Scholar]
  9. Preece A. W., Light P. A. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors. Clin Exp Immunol. 1974 Dec;18(4):543–552. [PMC free article] [PubMed] [Google Scholar]
  10. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation. Lancet. 1972 Sep 23;2(7778):627–629. doi: 10.1016/s0140-6736(72)93018-8. [DOI] [PubMed] [Google Scholar]
  11. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer Suppl. 1973 Aug;1:229–236. [PMC free article] [PubMed] [Google Scholar]
  12. Shelton J. B., Potter C. W., Carr I. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test. Br J Cancer. 1975 May;31(5):528–534. doi: 10.1038/bjc.1975.93. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES